Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 44Cholangiocarcinoma 5Liver Neoplasms 4Advanced Biliary Tract Cancer 3Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Biliary Tract Neoplasms 2Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Solid Tumors 1Small Cell Lung Carcinoma 1Recurrence 1Potentially Resectable Locally Advanced Malignant Tumors of Biliary System 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Liver Cirrhosis 1Klatskin Tumor 1Hepatoblastoma 1HER2-negative Advanced Gastric Cancer 1Gastric Cancer Metastatic to Liver 1Gallbladder Neoplasms 1First-line Treatment 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Tumor 1Biliary Tract Neoplasms Immunotherapy 1Advanced Primary Liver Cancer 1

Interventions

lenvatinib 3tislelizumab 2sintilimab 2theasinensin A 1sitravatinib 1S 1 (combination) 1Gemcitabine 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Advanced Biliary Tract Cancer × lenvatinib × Clear all
NCT05823987 2023-06-27

OPTIONS-05

Fudan University

Phase 2 Unknown
25 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown
25 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

NCT05410197 2022-10-12

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Sun Yat-sen University

Phase 2 Unknown
43 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡